Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Benitec Biopharma (BNTC) Gross Profit (2019 - 2021)

Historic Gross Profit for Benitec Biopharma (BNTC) over the last 6 years, with Q1 2024 value amounting to -$3000.0.

  • Benitec Biopharma's Gross Profit fell 10555.56% to -$3000.0 in Q1 2024 from the same period last year, while for Dec 2024 it was -$3000.0, marking a year-over-year increase of 9347.83%. This contributed to the annual value of -$108000.0 for FY2024, which is 24400.0% down from last year.
  • Latest data reveals that Benitec Biopharma reported Gross Profit of -$3000.0 as of Q1 2024, which was down 10555.56% from -$1000.0 recorded in Q4 2023.
  • Benitec Biopharma's Gross Profit's 5-year high stood at $54000.0 during Q1 2023, with a 5-year trough of -$106000.0 in Q3 2023.
  • Moreover, its 5-year median value for Gross Profit was -$1000.0 (2023), whereas its average is -$5266.7.
  • As far as peak fluctuations go, Benitec Biopharma's Gross Profit crashed by 122857.14% in 2020, and later skyrocketed by 90000.0% in 2022.
  • Benitec Biopharma's Gross Profit (Quarter) stood at -$18000.0 in 2020, then soared by 238.89% to $25000.0 in 2021, then plummeted by 44.0% to $14000.0 in 2022, then tumbled by 107.14% to -$1000.0 in 2023, then crashed by 200.0% to -$3000.0 in 2024.
  • Its last three reported values are -$3000.0 in Q1 2024, -$1000.0 for Q4 2023, and -$106000.0 during Q3 2023.